×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZVSA – zyversa therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZVSA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
08:14 am
zvsa
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/14
08:10 am
zvsa
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
Medium
Report
ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
11/12
08:35 am
zvsa
Life Sciences Investor Forum Agenda Announced for November 14th
Low
Report
Life Sciences Investor Forum Agenda Announced for November 14th
11/5
07:00 am
zvsa
ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistance and Type 2 Diabetes
High
Report
ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistance and Type 2 Diabetes
10/29
07:57 am
zvsa
ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs
Low
Report
ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs
10/22
08:14 am
zvsa
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases [Yahoo! Finance]
High
Report
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases [Yahoo! Finance]
10/22
07:57 am
zvsa
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
High
Report
ZyVersa Therapeutics Highlights Published Data Demonstrating That Obesity Results in Neuroinflammation Implicated in Development of Neurodegenerative Diseases
10/15
07:54 am
zvsa
ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors [Yahoo! Finance]
Medium
Report
ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome Inhibitors [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2024
08:10 am
ZVSA
zyversa therapeutics, inc.
BEAT
Report
-8.9%
zyversa therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
08:31 am
zvsa
Form 8-K ZyVersa Therapeutics, For: Nov 14
Medium
Report
Form 8-K ZyVersa Therapeutics, For: Nov 14
11/14
08:01 am
zvsa
Form 10-Q ZyVersa Therapeutics, For: Sep 30
Medium
Report
Form 10-Q ZyVersa Therapeutics, For: Sep 30
11/6
08:00 am
zvsa
Form 8-K ZyVersa Therapeutics, For: Nov 05
High
Report
Form 8-K ZyVersa Therapeutics, For: Nov 05
10/30
04:31 pm
zvsa
Form 8-K ZyVersa Therapeutics, For: Oct 29
Low
Report
Form 8-K ZyVersa Therapeutics, For: Oct 29
9/16
05:30 pm
zvsa
Form 8-K ZyVersa Therapeutics, For: Sep 16
High
Report
Form 8-K ZyVersa Therapeutics, For: Sep 16
9/16
05:30 pm
zvsa
Form 424B5 ZyVersa Therapeutics,
High
Report
Form 424B5 ZyVersa Therapeutics,
9/10
07:25 am
zvsa
Form 424B3 ZyVersa Therapeutics,
Medium
Report
Form 424B3 ZyVersa Therapeutics,
9/10
07:23 am
zvsa
Form 424B3 ZyVersa Therapeutics,
Medium
Report
Form 424B3 ZyVersa Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: